ADHD medication treatment and risk of psychosis.

[1]  P. Lichtenstein,et al.  Methylphenidate and the risk of psychosis in adolescents and young adults: a population-based cohort study , 2019, The lancet. Psychiatry.

[2]  S. Schneeweiss,et al.  Psychosis with Methylphenidate or Amphetamine in Patients with ADHD , 2019, The New England journal of medicine.

[3]  Elizabeth B. Owens,et al.  Young adult outcomes in the follow‐up of the multimodal treatment study of attention‐deficit/hyperactivity disorder: symptom persistence, source discrepancy, and height suppression , 2017, Journal of child psychology and psychiatry, and allied disciplines.

[4]  Elizabeth B. Owens,et al.  Functional Adult Outcomes 16 Years After Childhood Diagnosis of Attention-Deficit/Hyperactivity Disorder: MTA Results. , 2016, Journal of the American Academy of Child and Adolescent Psychiatry.

[5]  Liang-Jen Wang,et al.  Attention-deficit/hyperactivity disorder, methylphenidate use and the risk of developing schizophrenia spectrum disorders: A nationwide population-based study in Taiwan , 2015, Schizophrenia Research.

[6]  L. Hechtman,et al.  Reintroduction of stimulant treatment for patients with ADHD, after stimulant-related psychosis , 2014 .

[7]  L. Hechtman,et al.  Psychosis in a boy with ADHD treated with stimulants and acute lymphocytic leukemia treated with chemotherapy and steroids , 2013 .

[8]  J. Biederman,et al.  Risperidone treatment for ADHD in children and adolescents with bipolar disorder , 2008, Neuropsychiatric disease and treatment.